Tamaghna Mukherjee

WORK HISTORY

EDUCATION

ABOUT TAMAGHNA MUKHERJEE

I am an accomplished Global Pricing Manager at Novo Nordisk with a strong track record in strategic pricing and data-driven decision-making. With a focus on optimizing pricing strategies and delivering actionable insights, I bring valuable expertise to the pharmaceutical industry. In my role, I am responsible for conducting price optimization modelling analysis for both launch brands and in-market brands, ensuring that pricing decisions align with our organizational objectives. I take pride in optimizing and supporting standard pricing processes, conducting training sessions, and enhancing tool functionalities to streamline workflows. Over the course of my experience in pricing and market access with both Novartis and Qlaar Solutions, I have successfully coordinated with Global Pricing and Market Access Directors, taking a lead role in prioritizing and developing market access deliverables for Tropifexor and Iscalimab, assessed pricing and reimbursement landscapes for kidney transplant and conducted landscape assessments for osteoarthritis treatments. My skills in strategic recommendations, project management and market access have informed executive decisions. My expertise extends to analysing access landscapes in APMA countries, identifying current P&R scenarios, key access barriers and innovative access schemes. Additionally, I have managed various payer ad-board meetings and payer research projects, demonstrating strong project management skills. With a strong focus on continuous improvement, I have taken complete ownership of deliverables, driving pilot projects and meticulously tracking progress to ensure future stability. My dedication to superior customer satisfaction ensures that I provide high-quality support to both global and regional teams. My extensive background in pricing strategy, coupled with my ability to translate complex data into actionable insights, positions me as a valuable asset in driving market access and pricing strategies for organizations in the pharmaceutical sector.